How common was 2009 pandemic influenza A H1N1?

The Lancet Infectious Diseases

Volumn 11, Issue 6, 2011, Pages 423-424

  Kok, Jen ^a   Dywer, Dominic E ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ANTIBODY TITER; DISEASE ACTIVITY; HEMAGGLUTINATION; HUMAN; INCIDENCE; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LETTER; PRIORITY JOURNAL; SEROCONVERSION; SERODIAGNOSIS; SEROPREVALENCE;

ANTIBODIES, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PANDEMICS; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES;

EID: 79956278125     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70120-7     Document Type: Letter

References (12)

1. Gilbert GL, Cretikos MA, Hueston L, et al. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS ONE 2010, 5:e12562.
2. Kok J, Tudo K, Blyth CC, et al. Pandemic (H1N1) 2009 influenza virus seroconversion rates in HIV-infected individuals. J AIDS 2011, 56:91-94.
3. Chen MI, Lee VJ, Lim W, et al. 2009 Influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 2010, 303:1383-1391.
4. McVernon J, Laurie K, Nolan T, et al. Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October-December 2009. Euro Surveill 2010, 15. pii=19678.
5. Miller E, Hoschler K, Hardelid P, et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010, 375:1100-1108.
6. Waalen K, Kilander A, Dudman SG, et al. High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill 2010, 15. pii=19633.
7. Aho M, Lyytikaïnen O, Nyholm JE, et al. Outbreak of 2009 pandemic influenza A(H1N1) in a Finnish garrison-a serological survey. Euro Surveill 2010, 15. pii=19709.
8. Adamson WE, Maddi S, Robertson C, et al. 2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak. Euro Surveill 2010, 15:pii=19590.
9. Wu JT, Ma ES, Lee CK, et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010, 51:1184-1191.
10. Guidance for industry: clinical data needed to support licensure of pandemic influenza vaccines U.S. Department of Health and Human Service Food and Drug Administration Center for Biologics Evaluation and Research, (accessed Dec 8, 2010). http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm091985.pdf.
11. Loeb M, Dafoe N, Mahony J, et al. Surgical mask vs N95 respirator for preventing influenza among health care workers. JAMA 2009, 302:1865-1871.
12. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361:1945-1952.